Simpson Thacher is representing McKesson Corporation (NYSE: MCK, “McKesson”) in its announced agreement to acquire Rx Savings Solutions (RxSS), a prescription price transparency and benefit insight company that offers affordability and adherence solutions to health plans and employers, reaching more than 17 million current patients.
The transaction is valued up to $875 million, which includes a $600 million upfront payment and a maximum of $275 million of consideration contingent upon RxSS’ financial performance through calendar year 2025. The transaction is subject to customary closing conditions, including regulatory review.
McKesson is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Its teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services to help make quality care more accessible and affordable.
Founded by pharmacist Michael Rea, RxSS helps members and payers reduce prescription drug costs through a combination of clinical technology, transparency, member engagement and concierge support. Currently 17 million members have access to personalized recommendations for lowering prescription costs and dedicated pharmacy experts to help navigate benefits, providers and pharmacies.
The Simpson Thacher team includes Naveed Anwar, Fred de Albuquerque, Koh Tanimoto, Michaela Dion, Jamie Lee and Mariel McClenahan (M&A); Sophie Staples, Caroline Phillips and Ruoxi Zhang (Tax); Tristan Brown, Ryan Stott and Ryan Kenny (ECEB); and Lori Lesser, Bobbie Burrows and Mark Natividad (Intellectual Property).